The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

The ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.

In obesity, it will compete with Novo Nordisk’s GLP-1 agonist Wegovy (semaglutide), which launched in limited quantities in the UK last September and is also recommended by NICE. Novo Nordisk ...

Here are some of the major companies whose stocks moved on the week’s news.

Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its ...

Caretaker CM Eknath Shinde returns to his village amid talks of forming Maharashtra's new cabinet. BJP pushes for Devendra Fadnavis as CM, with Shinde and Ajit Pawar as possible deputies.

These 3 iPad Pro Features Should Come to the iPhone ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...